ECO Animal Health Group (EAH) Competitors

GBX 109.60
+7.10 (+6.93%)
(As of 04:18 PM ET)

EAH vs. CEL, VLG, ANCR, AGY, BXP, APH, POLB, SPEC, ETX, and NCYT

Should you be buying ECO Animal Health Group stock or one of its competitors? The main competitors of ECO Animal Health Group include Celadon Pharmaceuticals (CEL), Venture Life Group (VLG), Animalcare Group (ANCR), Allergy Therapeutics (AGY), Beximco Pharmaceuticals (BXP), Alliance Pharma (APH), Poolbeg Pharma (POLB), INSPECS Group (SPEC), e-therapeutics (ETX), and Novacyt (NCYT). These companies are all part of the "medical" sector.

ECO Animal Health Group vs.

ECO Animal Health Group (LON:EAH) and Celadon Pharmaceuticals (LON:CEL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, community ranking, profitability, valuation, institutional ownership and risk.

Celadon Pharmaceuticals has a consensus price target of GBX 222.50, suggesting a potential upside of 111.90%. Given Celadon Pharmaceuticals' higher probable upside, analysts plainly believe Celadon Pharmaceuticals is more favorable than ECO Animal Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Celadon Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

95.9% of ECO Animal Health Group shares are held by institutional investors. Comparatively, 5.5% of Celadon Pharmaceuticals shares are held by institutional investors. 17.0% of ECO Animal Health Group shares are held by insiders. Comparatively, 73.2% of Celadon Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ECO Animal Health Group has higher revenue and earnings than Celadon Pharmaceuticals. ECO Animal Health Group is trading at a lower price-to-earnings ratio than Celadon Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECO Animal Health Group£88.46M0.84-£1.62M-£0.02-5,480.00
Celadon Pharmaceuticals£11.26K5,988.67-£7.96M-£0.13-807.69

ECO Animal Health Group received 288 more outperform votes than Celadon Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Celadon Pharmaceuticals an outperform vote while only 75.65% of users gave ECO Animal Health Group an outperform vote.

CompanyUnderperformOutperform
ECO Animal Health GroupOutperform Votes
292
75.65%
Underperform Votes
94
24.35%
Celadon PharmaceuticalsOutperform Votes
4
100.00%
Underperform Votes
No Votes

Celadon Pharmaceuticals has a net margin of 0.00% compared to ECO Animal Health Group's net margin of -1.83%. ECO Animal Health Group's return on equity of -0.24% beat Celadon Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
ECO Animal Health Group-1.83% -0.24% 0.69%
Celadon Pharmaceuticals N/A -122.33%-35.60%

In the previous week, ECO Animal Health Group had 1 more articles in the media than Celadon Pharmaceuticals. MarketBeat recorded 1 mentions for ECO Animal Health Group and 0 mentions for Celadon Pharmaceuticals. ECO Animal Health Group's average media sentiment score of 0.00 equaled Celadon Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
ECO Animal Health Group Neutral
Celadon Pharmaceuticals Neutral

Summary

ECO Animal Health Group beats Celadon Pharmaceuticals on 8 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EAH vs. The Competition

MetricECO Animal Health GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£74.24M£1.07B£4.84B£1.40B
Dividend Yield0.94%3.02%2.96%12.00%
P/E Ratio-5,480.001,164.51170.891,723.22
Price / Sales0.849,525.472,457.49310,875.70
Price / Cash6.0510.1446.2832.85
Price / Book0.913.274.752.52
Net Income-£1.62M£102.53M£103.00M£179.82M
7 Day Performance16.60%-0.54%0.60%13.91%
1 Month Performance29.70%-0.20%-6.35%4.43%
1 Year Performance-6.72%29.23%9.63%16.76%

ECO Animal Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CEL
Celadon Pharmaceuticals
0 of 5 stars
GBX 115
flat
GBX 222.50
+93.5%
-34.4%£73.84M£11,258.00-884.6224Gap Up
VLG
Venture Life Group
0 of 5 stars
GBX 41
+1.2%
N/A-1.9%£51.87M£48.57M-4,100.00153News Coverage
ANCR
Animalcare Group
0 of 5 stars
GBX 217
flat
N/A+19.5%£130.44M£74.35M10,850.00220News Coverage
AGY
Allergy Therapeutics
0 of 5 stars
GBX 2.80
-1.8%
N/A-54.4%£133.56M£59.59M-46.67612
BXP
Beximco Pharmaceuticals
0 of 5 stars
GBX 37
flat
N/AN/A£165.06M£41.65B462.505,700
APH
Alliance Pharma
2.358 of 5 stars
GBX 35.85
+1.0%
GBX 80.75
+125.2%
-42.5%£193.73M£170.05M-3,585.00285
POLB
Poolbeg Pharma
0 of 5 stars
GBX 10.55
+3.4%
N/A+55.9%£52.75MN/A-1,055.0012
SPEC
INSPECS Group
0 of 5 stars
GBX 51.70
-0.6%
N/A-47.6%£52.56M£202M-2,585.001,732
ETX
e-therapeutics
0 of 5 stars
GBX 8.86
+0.1%
N/A-32.6%£51.76M£295,000.00-442.9034Gap Down
NCYT
Novacyt
0 of 5 stars
GBX 68.60
+0.9%
N/A+31.9%£48.45M£7.87M-190.56120Gap Up

Related Companies and Tools

This page (LON:EAH) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners